GeneXpert Testing: Applications for Clinical Microbiology, Part II

Elizabeth M. Marlowe; Donna M. Wolk

doi:10.1016/j.clinmicnews.2008.11.004

GeneXpert Testing: Applications for Clinical Microbiology, Part II

Elizabeth M. Marlowe, Donna M. Wolk

Pathology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

The impact of rapid polymerase chain reaction (PCR) technology on infectious-disease testing is continuing to evolve outside the realm of a centralized laboratory. The GeneXpert Dx system is the first unit dose, near-point-of-care, molecular device commercially available. Part I of this two-part article addressed the use of the GeneXpert system for the detection of group B Streptococcus, enterovirus, and methicillin-resistant and methicillin-susceptible Staphylococcus aureus in various clinical specimens. Part II of this article will review the advantages and disadvantages of conventional culture methods and alternative molecular technologies along with the GeneXpert system, for the detection of these microorganisms in clinical specimens.

Original language	English (US)
Pages (from-to)	183-188
Number of pages	6
Journal	Clinical Microbiology Newsletter
Volume	30
Issue number	24
DOIs	https://doi.org/10.1016/j.clinmicnews.2008.11.004
State	Published - Dec 15 2008

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1016/j.clinmicnews.2008.11.004

Cite this

@article{5d4e2c5663be49b582bfc4f947c2c691,

title = "GeneXpert Testing: Applications for Clinical Microbiology, Part II",

abstract = "The impact of rapid polymerase chain reaction (PCR) technology on infectious-disease testing is continuing to evolve outside the realm of a centralized laboratory. The GeneXpert Dx system is the first unit dose, near-point-of-care, molecular device commercially available. Part I of this two-part article addressed the use of the GeneXpert system for the detection of group B Streptococcus, enterovirus, and methicillin-resistant and methicillin-susceptible Staphylococcus aureus in various clinical specimens. Part II of this article will review the advantages and disadvantages of conventional culture methods and alternative molecular technologies along with the GeneXpert system, for the detection of these microorganisms in clinical specimens.",

author = "Marlowe, {Elizabeth M.} and Wolk, {Donna M.}",

year = "2008",

month = dec,

day = "15",

doi = "10.1016/j.clinmicnews.2008.11.004",

language = "English (US)",

volume = "30",

pages = "183--188",

journal = "Clinical Microbiology Newsletter",

issn = "0196-4399",

publisher = "Elsevier Inc.",

number = "24",

}

TY - JOUR

T1 - GeneXpert Testing

T2 - Applications for Clinical Microbiology, Part II

AU - Marlowe, Elizabeth M.

AU - Wolk, Donna M.

PY - 2008/12/15

Y1 - 2008/12/15

N2 - The impact of rapid polymerase chain reaction (PCR) technology on infectious-disease testing is continuing to evolve outside the realm of a centralized laboratory. The GeneXpert Dx system is the first unit dose, near-point-of-care, molecular device commercially available. Part I of this two-part article addressed the use of the GeneXpert system for the detection of group B Streptococcus, enterovirus, and methicillin-resistant and methicillin-susceptible Staphylococcus aureus in various clinical specimens. Part II of this article will review the advantages and disadvantages of conventional culture methods and alternative molecular technologies along with the GeneXpert system, for the detection of these microorganisms in clinical specimens.

AB - The impact of rapid polymerase chain reaction (PCR) technology on infectious-disease testing is continuing to evolve outside the realm of a centralized laboratory. The GeneXpert Dx system is the first unit dose, near-point-of-care, molecular device commercially available. Part I of this two-part article addressed the use of the GeneXpert system for the detection of group B Streptococcus, enterovirus, and methicillin-resistant and methicillin-susceptible Staphylococcus aureus in various clinical specimens. Part II of this article will review the advantages and disadvantages of conventional culture methods and alternative molecular technologies along with the GeneXpert system, for the detection of these microorganisms in clinical specimens.

UR - http://www.scopus.com/inward/record.url?scp=57049157771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57049157771&partnerID=8YFLogxK

U2 - 10.1016/j.clinmicnews.2008.11.004

DO - 10.1016/j.clinmicnews.2008.11.004

M3 - Article

AN - SCOPUS:57049157771

SN - 0196-4399

VL - 30

SP - 183

EP - 188

JO - Clinical Microbiology Newsletter

JF - Clinical Microbiology Newsletter

IS - 24

ER -

GeneXpert Testing: Applications for Clinical Microbiology, Part II

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this